PTCT
PTC THERAPEUTICS, INC.
PTC THERAPEUTICS, INC. (PTCT) has 18 SEC Form 4 filings (168 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory with 9 filings. Insiders have net sold $13.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Matthew Klein
- Employees:939
- HQ:Warren, NJ, US
- IPO:2013-06-20
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$34.6M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Market Cap
$647.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Gravier PierreFirst filing | CHIEF FINANCIAL OFFICER | Sale | 3,494 | $281K | Jul 16 | SEC ↗ |
Smith Mary L.First filing | Director | Sale | 15,834 | $1.4M | Jul 13 | SEC ↗ |
| CHIEF TECHNICAL OPS OFFICER | Sale | 2,464 | $222K | Jul 13 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 5,079 | $432K | Jul 8 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 22,161 | $1.9M | Jul 8 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 24,613 | $2.2M | Jul 8 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 8,130 | $693K | Jun 30 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 5,323 | $453K | Jun 26 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 20,960 | $1.8M | Jun 26 | SEC ↗ | |
Almstead Neil GregoryFirst in 7 months | CHIEF TECHNICAL OPS OFFICER | Sale | 23,749 | $1.9M | Jun 24 | SEC ↗ |
Boulding Mark ElliottFirst in 6 months | EXEC. VP AND CLO | Sale | 10,462 | $823K | Jun 22 | SEC ↗ |
Utter Christine MarieFirst filing | SVP, CHIEF ACCOUNTING OFFICER | Sale | 19,686 | $1.5M | Jun 22 | SEC ↗ |
Boulding Mark ElliottFirst in 3 months | EXEC. VP AND CLO | Sale | 1,739 | $134K | Jan 8 | SEC ↗ |
Boulding Mark ElliottFirst in 3 months | EXEC. VP AND CLO | Sale | 4,879 | $378K | Jan 8 | SEC ↗ |
Pauwels EricFirst filing | CHIEF BUSINESS OFFICER | Sale | 40,190 | $3.0M | Dec 19 | SEC ↗ |
Pauwels EricFirst filing | CHIEF BUSINESS OFFICER | Sale | 3,202 | $240K | Dec 19 | SEC ↗ |
Almstead Neil GregoryFirst filing | CHIEF TECHNICAL OPS OFFICER | Sale | 71,928 | $6.0M | Nov 26 | SEC ↗ |
Jacobson Allan StevenFirst filing | Insider | Sale | 11,801 | $946K | Nov 26 | SEC ↗ |
Jacobson Allan StevenFirst filing | Insider | Sale | 14,199 | $1.2M | Nov 26 | SEC ↗ |
Almstead Neil GregoryFirst filing | CHIEF TECHNICAL OPS OFFICER | Sale | 35,572 | $2.9M | Nov 26 | SEC ↗ |
Reeve EmmaFirst filing | Insider | Sale | 25,562 | $1.7M | Oct 7 | SEC ↗ |
| EXEC. VP AND CLO | Sale | 22,655 | $1.5M | Oct 7 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 2,266 | $147K | Oct 7 | SEC ↗ | |
Boulding Mark ElliottFirst filing | EXEC. VP AND CLO | Sale | 22,664 | $1.4M | Sep 15 | SEC ↗ |
Boulding Mark ElliottFirst filing | EXEC. VP AND CLO | Sale | 24,585 | $1.5M | Sep 15 | SEC ↗ |
Related companies
PTC THERAPEUTICS, INC. is in the Healthcare sector.